The cooperation project MICROBELIX was jointly launched in spring 2023 by researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the Naturlandstiftung Saar (NLS). Together, both...
Saarbrücken, 21. September, 2023 - Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have again succeeded in acquiring funding under the BMBF-funded "GO-Bio Iinitial" program. The...
The list of “Highly-cited researchers” is published annually by Clarivate Analytics to honor scientists who have made a particularly significant impact in their fields. Five heads of department at the Helmholtz Centre...
Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal...
In the context of the tenure negotiations for Drug Bioinformatics Professor Olga Kalinina, the Klaus Faber Foundation is providing €100,000 to the "bioINFpro" project, thereby enabling her long-term stay at the...
Researchers from the Department of Drug Design and Optimisation have developed molecules that can drastically reduce the pathogenic effects of the hospital germ Pseudomonas aeruginosa. In this interview, the authors Dr....
Sustainable and environmentally friendly production processes are playing an increasingly important role in almost all branches of industry. The production of active pharmaceutical ingredients in particular involves the...
In a new study, an international research team shows that the very cotton buds, which we all got to know so intimately during the COVID-19 pandemic, are a valuable tool to map biodiversity. This was the result of an...
How SARS-CoV-2 initiates its replication process during infection is not yet fully understood. Researchers from the Helmholtz Institute Würzburg have now shown for the first time in the journal Cell that it is the human...
